Vermilyea Scott C, Lu Jianfeng, Olsen Miles, Guthrie Scott, Tao Yunlong, Fekete Eva M, Riedel Marissa K, Brunner Kevin, Boettcher Carissa, Bondarenko Viktorya, Brodsky Ethan, Block Walter F, Alexander Andrew, Zhang Su-Chun, Emborg Marina E
Cell Transplant. 2017 Apr 13;26(4):613-624. doi: 10.3727/096368916X692979. Epub 2016 Sep 14.
Induced pluripotent stem cell (iPSC)-derived neurons represent an opportunity for cell replacement strategies for neurodegenerative disorders such as Parkinson's disease (PD). Improvement in cell graft targeting, distribution, and density can be key for disease modification. We have previously developed a trajectory guide system for real-time intraoperative magnetic resonance imaging (RT-IMRI) delivery of infusates, such as viral vector suspensions for gene therapy strategies. Intracerebral delivery of iPSC-derived neurons presents different challenges than viral vectors, including limited cell survival if cells are kept at room temperature for prolonged periods of time, precipitation and aggregation of cells in the cannula, and obstruction during injection, which must be solved for successful application of this delivery approach. To develop procedures suitable for RT-IMRI cell delivery, we first performed in vitro studies to tailor the delivery hardware (e.g., cannula) and defined a range of parameters to be applied (e.g., maximal time span allowable between cell loading in the system and intracerebral injection) to ensure cell survival. Then we performed an in vivo study to evaluate the feasibility of applying the system to nonhuman primates. Our results demonstrate that the RT-IMRI delivery system provides valuable guidance, monitoring, and visualization during intracerebral cell delivery that are compatible with cell survival.
诱导多能干细胞(iPSC)衍生的神经元为帕金森病(PD)等神经退行性疾病的细胞替代策略提供了契机。改善细胞移植的靶向性、分布和密度可能是疾病改善的关键。我们之前开发了一种轨迹引导系统,用于在实时术中磁共振成像(RT-IMRI)下输送诸如用于基因治疗策略的病毒载体悬浮液等注入物。与病毒载体相比,iPSC衍生的神经元的脑内递送面临不同的挑战,包括如果细胞在室温下长时间保存则细胞存活率有限、细胞在套管中沉淀和聚集以及注射过程中的阻塞,要成功应用这种递送方法必须解决这些问题。为了开发适合RT-IMRI细胞递送的程序,我们首先进行了体外研究,以定制递送硬件(如套管),并确定一系列要应用的参数(如系统加载细胞与脑内注射之间允许的最大时间跨度)以确保细胞存活。然后我们进行了一项体内研究,以评估将该系统应用于非人灵长类动物的可行性。我们的结果表明,RT-IMRI递送系统在脑内细胞递送过程中提供了与细胞存活兼容的有价值的引导、监测和可视化。